therapeutics

23andMe at Annual Meeting of the American Society of Human Genetics

October 15, 2018
More than 50 23andMe scientists will be participating in the annual meeting of the American Society of Human Genetics in San Diego this year.
Read More

A Note On 23andMe’s New Collaboration with GSK

July 25, 2018
23andMe announces the launch of a collaboration with GlaxoSmithKline (GSK) to accelerate our ability to make meaningful discoveries in therapeutics to treat disease.
Read More

23andMe’s CEO Featured On The Today Show

October 17, 2016
As part of a series on cutting edge women, The Today Show featured Anne Wojcicki, 23andMe’s CEO and co-founder. The NBC crew followed Anne as she hustled through a typical...
Read More

Find Us At ASHG

October 13, 2016
Attending the annual American Society of Human Genetics meeting in Vancouver next week?We’d love to hear from you! Attend our talks, come by our posters, and find us at our...
Read More

23andMe Scientists To Present New Findings

October 06, 2016
23andMe scientists will be at the annual American Society of Human Genetics meeting in Vancouver this month sharing a wide spectrum of interesting data that includes more on the genetics...
Read More

What’s New In Parkinson’s Research

November 18, 2015
The panel discussing Parkinson’s Progression Marker Initiative at the MJFF’s Parkinson’s Disease Therapeutics Conference in New York. From implanting cells into the brain to prevent the loss of dopamine producing...
Read More

Richard Scheller Named to National Academy of Medicine

October 19, 2015
Growing up 23andMe’s chief science officer Richard Scheller, Ph.D., had classmates in his elementary school, who wanted to be a firemen, police officers and astronauts.Richard always wanted to be a...
Read More

The Future of Health Care

July 07, 2015
Anne Wojcicki, 23andMe’s CEO and co-founder, spoke recently with Kai Ryssdal, the host and senior editor at Marketplace, about the company, genetics, and the future of health care. It’s a...
Read More

A Computational Biologist And A Gentleman

May 22, 2015
Over the last few months 23andMe has assembled a virtual dream team to make up its therapeutics group. Starting with the appointment of Richard Scheller, Ph.D. as chief science officer...
Read More